Surveys, Registries, Interviews
Online survey on stomach cancer risk for people with an inherited mutation in genes that are linked to an increased risk of certain cancers
Study Contact Information:
Please contact:
Diane Rose (FORCE) at (866) 288- 7475 x 712 or [email protected], or Luis Carvajal-Carmona, PhD, (UC Davis) at (530)-754-5301 or [email protected]
The purpose of this study is to understand gastric (stomach) cancer risk among people with an inherited (germline) mutation in genes that are linked to an increased risk of certain cancers, including APC, ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), MUTYH, STK11, and other genes linked to increased cancer risk.
We would like to invite you to complete an anonymous survey conducted by FORCE and researchers from the University of California, Davis. The survey is open to people with or without stomach cancer in their family.
This is a confidential, anonymous online survey that will take about 15 minutes to complete. The survey responses will be used to conduct this study and the data collected for this research may also be used for future research studies. We will not share any personally identifiable information.
Complete the survey in English
Complete the survey in Spanish
Sue Friedman, DVM, FORCE
Luis Carvajal-Carmona, PhD, UC Davis
Individuals who are 18 years of age or older and who speak either English or Spanish may be eligible if they have an inherited mutation in a gene associated with a higher risk of certain cancers. This includes genes such as APC, ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, those linked to Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), MUTYH, STK11, and other genes related to increased cancer risk.
People under the age of 18 who do not speak English or Spanish and who do not have an inherited mutation in a gene that is linked to an increased risk of cancer.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.